Anti-TNF antibody modulates cytokine and MHC expression in cardiac allografts

Journal of Surgical Research

Volumn 81, Issue 2, 1999, Pages 123-128

  Wei, Ru Qi ^a   Schwartz, Charles F ^a   Lin, Hua ^a   Chen, Gwo Hsiao ^a   Bolling, Steven F ^a,b  

^a UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^b UNIVERSITY OF MICHIGAN HOSPITALS   (United States)

Author keywords

Rejection; TNF; Transplantation

Indexed keywords

BETA ACTIN; COMPLEMENTARY DNA; CYTOKINE; INTERFERON; INTERLEUKIN 10; INTERLEUKIN 2; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MESSENGER RNA; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR ANTIBODY;

ALLOGRAFT; ANIMAL CELL; ANIMAL MODEL; ANTIGEN EXPRESSION; ARTICLE; CONTROLLED STUDY; FLOW CYTOMETRY; GENE EXPRESSION; GRAFT REJECTION; GRAFT SURVIVAL; HEART TRANSPLANTATION; IMMUNOMODULATION; INTRAPERITONEAL DRUG ADMINISTRATION; MAJOR HISTOCOMPATIBILITY COMPLEX; MALE; NONHUMAN; ORGAN TRANSPLANTATION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RAT; SPLEEN CELL;

EID: 0033079611     PISSN: 00224804     EISSN: None     Source Type: Journal    
DOI: 10.1006/jsre.1998.5303     Document Type: Article

References (27)

1. Beutler, B., Greenwald, D., Hulmes, J. D., Chang, M., Pan, Y.-C.E., Mathison, J., Ulevitch, R., and Cerami, A. Identity of tumor necrosis factor and the macrophage-secreted factor cachectin. Nature 316: 552, 1985.
2. Sung, S., Bjorndahi, J. M., Wang, C. Y., Kao, H. T., and Fu, S. M. Production of tumor necrosis factor/cachectin by human T cell lines and peripheral blood T lymphocytes stimulated by phobolmyristate acetate and anti-CD3. J. Exp. Med. 167: 937, 1988.
3. Sung, S.-S. J., Jung, L. K., Walters, J. A., Chen, W., Wang, C. Y., and Fu, S. M. Production of tumor necrosis factor/cachectin by human cell lines and tonsillar cells. J. Exp. Med. 168: 1539, 1988.
4. Peters, P. M., Ortaido, J. R., Shalaby, M. R., Svedersky, L. P., Nedwin, G. E., Bringman, T. S., Hass, P. E., Aggarwal, B. B., Herberman, R. B., Goeddel, J. C., and Palladino, M. A. Natural-killer sensitive targets stimulate production of TNF-α, but not TNF-β(lymphotoxin) by highly purified human peripheral blood large granular lymphocytes. J. Immunol. 137: 2592, 1986.
5. Gordon, J. R., and Galli, S. J. Mast cells as a source of both performed and immunologically inducible TNF-a/cachectin. Nature 346: 274, 1990.
6. Colletti, L. M., Burtch, G. D., Remick, D. G., Kunkel, S. L., Strieter, R. M., Guice, K. S., Oldman, K. T., and Campbell, D., Jr. The production of tumor necrosis factor alpha and the development of a pulmonary capillary injury following hepatic ischemia/reperfusion. J. Immunol. 49: 268, 1990.
7. Shalaby, M. R., Palladino, M. A., Jr., Hirabayashi, S. E., Eessalu, T. E., Lewis, G. D., Shepard, H. M., and Aggarwal, B. B. Receptor binding and activation of polymorphonuclear neutrophils by tumor necrosis factor-alpha. J. Leukocyte Biol. 41: 196, 1987.
8. Collart, M. A., Belin, D., Vassalli, J. D., Kossodo, S. D. E., and Vassalli, P. γ Interferon enhances macrophage transcription of the tumor necrosis factor/cachectin, interleukin 1 and urokinase genes, which are controlled by short-lived repressors. J. Exp. Med. 164: 2113, 1986.
9. Yokota, S., Geppert, T. D., and Lipsky, P. E. Enhancement of antigen and mitogen induced human T lymphocyte proliferation by tumor necrosis factor. J. Immunol. 140: 531, 1988.
10. Maury, C. J., and Teppo, A. M. Raised serum levels of cachectin/tumor necrosis factor in renal allograft rejection. J. Exp. Med. 166: 1132, 1987.
11. Imagawa, D. K., Millis, J. M., Olthoff, K., et al. The role of tumor necrosis factor in allograft rejection: I. Elevated levels of tumor necrosis factor alpha predict rejection flowing orthotopic liver transplantation. Transplantation 50: 219, 1990.
12. Chang, R. J., and Lee, S. H. Effects of interferon-r and tumor necrosis factor-a on the expression of Ia antigen on a murine macrophage cell line. J. Immunol. 137: 2853, 1986.
13. Lin, H., Chensue, S. W., Strieter, R. M., Remik, D. G., Gallagher, K. P., Bolling, S. F., and Kunkel, S. L. Antibodies against tumor necrosis factor prolong heart allograft survival in the rat. J. Heart Lung Transplant. 11: 330, 1992.
14. Bolling, S. F., Kunkel, S. L., and Lin, H. Anti-TNF and cyclosporine combination therapy prolongs cardiac allograft survival in rats. Transplantation XL III: 413, 1992.
15. Wei, R. Q., Lin, H., and Bolling, S. F. Inhibition of tumor necrosis factor-alpha (TNF-a) production in lymphocytes from anti-TNF antibody treated grafting rat. J. Surg. Res. 56: 601, 1994.
16. Lin, H., Wei, R. Q., and Bolling, S. F. Tumor necrosis factor-alpha and interferon modulation of nitric oxide and allograft survival. J. Surg. Res., in press.
17. Lin, H., Iannettoni, M. D., Goldblum, J. R., and Bolling, S. F. Experimental heterotopic heart transplantation without ischemia or reperfusion. J. Heart Transplant. 9: 720, 1990.
18. Remick, D. G., Strieter, R. M., Eskandari, M. K., et al. Role of tumor necrosis factor alpha in lipopolysacharide-induced pathologic alterations. Am. J. Pathol. 136: 49, 1990.
19. Grau, G. E., Fajardo, L. F., Piguet, P. F., Allet, B., Lambert, P. H., and Vassalli, P. Tumor necrosis factor/cachetin as an essential mediator in murine cerebral malaria. Science 237: 1210, 1987.
20. Imagawa, D. K., Millis, J. M., Olthoff, K. M., Heart, J., Wasef, E., Dempsey, R. A., Stephens, S., and Busuttil, R. W. The role of tumor necrosis factor in allograft rejection. III. Anti-TNF anti-body therapy prolongs allograft survival in rats with acute rejection. Transplantation 51: 57, 1991.
21. Piguet, P. F., Grau, G. E., Allet, B., and Vassli, P. Tumor necrosis factor/cachectin is an effector of skin and gut lesion of the acute phase of graft-vs-host disease. J. Exp. Med. 166: 1280, 1987.
22. Zembala, M., Siedlar, M., Ruggiero, I., Wieckiewicz, J., Mytar, B., Mattei, M., and Colizzi, V. The MHC class-II and CD44 molecules are involved in the induction of tumour necrosis factor (TNF) gene expression by human monocytes stimulated with tumour cells. Int. J. Cancer 56(2): 269, 1994.
23. Panek, R. B., and Benveniste, E. N. Class II MHC gene expression in microglia. Regulation by the cytokines IFN-gamma, TNF-alpha, and TGF-beta. J. Immunol. 154(6): 2846, 1995.
24. Wang, Z. Y., Link, H., Ljungdahl, A., Hojeberg, B., Link, J., He, B., Qiao, J., Melms, A., and Olsson, T. Induction of interferon-gamma, interleukin-4, and transforming growth factor-beta in rats orally tolerized against experimental autoimmune myasthenia gravis. Cell. Immunol. 157(2): 353, 1994.
25. Burstein, H. J., and Abbas, A. K. In vivo role of interleukin 4 in T cell tolerance induced by aqueous protein antigen. J. Exp. Med. 177(2): 457, 1993.
26. Rivas, J. M., and Ullrich, S. E. The role of IL-4, IL-10, and TNF-alpha in the immune suppression induced by ultraviolet radiation. J. Leukocyte Biol. 56(6): 769, 1994.
27. Abramowicz, D., Durez, P., Gerard, C., Donckier, V., Amraoui, Z., Velu, T., and Goldman, M. Neonatal induction of transplantation tolerance in mice is associated with in vivo expression of IL-4 and -10 mRNAs. Transplant. Proc. 25: 312, 1993.